Literature DB >> 21653853

Specific regulation of NRG1 isoform expression by neuronal activity.

Xihui Liu1, Ryan Bates, Dong-Min Yin, Chengyong Shen, Fay Wang, Nan Su, Sergei A Kirov, Yuling Luo, Jian-Zhi Wang, Wen-Cheng Xiong, Lin Mei.   

Abstract

Neuregulin 1 (NRG1) is a trophic factor that has been implicated in neural development, neurotransmission, and synaptic plasticity. NRG1 has multiple isoforms that are generated by usage of different promoters and alternative splicing of a single gene. However, little is known about NRG1 isoform composition profile, whether it changes during development, or the underlying mechanisms. We found that each of the six types of NRG1 has a distinct expression pattern in the brain at different ages, resulting in a change in NRG1 isoform composition. In both human and rat, the most dominant are types III and II, followed by either type I or type V, while types IV and VI are the least abundant. The expression of NRG1 isoforms is higher in rat brains at ages of E13 and P5 (in particular type V), suggesting roles in early neural development and in the neonatal critical period. At the cellular level, the majority of NRG1 isoforms (types I, II, and III) are expressed in excitatory neurons, although they are also present in GABAergic neurons and astrocytes. Finally, the expression of each NRG1 isoform is distinctly regulated by neuronal activity, which causes significant increase in type I and IV NRG1 levels. Neuronal activity regulation of type IV expression requires a CRE cis-element in the 5' untranslated region (UTR) that binds to CREB. These results indicate that expression of NRG1 isoforms is regulated by distinct mechanisms, which may contribute to versatile functions of NRG1 and pathologic mechanisms of brain disorders such as schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653853      PMCID: PMC3154699          DOI: 10.1523/JNEUROSCI.5317-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  100 in total

1.  Glial growth factor 2 induces proliferation and structural changes in ensheathing cells.

Authors:  M I Chuah; J Cossins; E Woodhall; R Tennent; G Nash; A K West
Journal:  Brain Res       Date:  2000-02-28       Impact factor: 3.252

2.  A case control and family based association study of the neuregulin1 gene and schizophrenia.

Authors:  X Zhao; Y Shi; J Tang; R Tang; L Yu; N Gu; G Feng; S Zhu; H Liu; Y Xing; S Zhao; H Sang; Y Guan; D St Clair; L He
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

3.  Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain.

Authors:  R Eilam; R Pinkas-Kramarski; B J Ratzkin; M Segal; Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

4.  Development of the barrels and barrel field in the somatosensory cortex of the mouse.

Authors:  F L Rice; H Van der Loos
Journal:  J Comp Neurol       Date:  1977-02-15       Impact factor: 3.215

5.  Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.

Authors:  Lei Wen; Yi-Sheng Lu; Xin-Hong Zhu; Xiao-Ming Li; Ran-Sook Woo; Yong-Jun Chen; Dong-Min Yin; Cary Lai; Alvin V Terry; Almira Vazdarjanova; Wen-Cheng Xiong; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-29       Impact factor: 11.205

6.  Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke.

Authors:  Zhenfeng Xu; Ju Jiang; Gregory Ford; Byron D Ford
Journal:  Biochem Biophys Res Commun       Date:  2004-09-17       Impact factor: 3.575

Review 7.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

8.  Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus.

Authors:  A P Corvin; D W Morris; K McGhee; S Schwaiger; P Scully; J Quinn; D Meagher; D St Clair; J L Waddington; M Gill
Journal:  Mol Psychiatry       Date:  2004-02       Impact factor: 15.992

9.  Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex.

Authors:  E S Anton; M A Marchionni; K F Lee; P Rakic
Journal:  Development       Date:  1997-09       Impact factor: 6.868

10.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.

Authors:  Nadine Norton; Valentina Moskvina; Derek W Morris; Nicholas J Bray; Stanley Zammit; Nigel M Williams; Hywel J Williams; Anna C Preece; Sarah Dwyer; Jennifer C Wilkinson; Gillian Spurlock; George Kirov; Paul Buckland; John L Waddington; Michael Gill; Aiden P Corvin; Michael J Owen; Michael C O'Donovan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

View more
  84 in total

1.  The ketogenic diet increases Neuregulin 1 expression via elevating histone acetylation and its anti-seizure effect requires ErbB4 kinase activity.

Authors:  Jin Wang; Jie Huang; Shan Yao; Jia-Hui Wu; Hui-Bin Li; Feng Gao; Ying Wang; Guo-Bin Huang; Qiang-Long You; Jianhua Li; Xiaohui Chen; Xiang-Dong Sun
Journal:  Cell Biosci       Date:  2021-05-21       Impact factor: 7.133

Review 2.  Developmental neuromuscular synapse elimination: Activity-dependence and potential downstream effector mechanisms.

Authors:  Young Il Lee
Journal:  Neurosci Lett       Date:  2019-12-23       Impact factor: 3.046

Review 3.  Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.

Authors:  Chiara Fabbri; Alessandro Serretti
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

Review 4.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

5.  Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AG.

Authors:  Huizhi Du; In-Kiu Kwon; Jimok Kim
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

6.  Structural Similarities between Neuregulin 1-3 Isoforms Determine Their Subcellular Distribution and Signaling Mode in Central Neurons.

Authors:  Detlef Vullhorst; Tanveer Ahmad; Irina Karavanova; Carolyn Keating; Andres Buonanno
Journal:  J Neurosci       Date:  2017-04-21       Impact factor: 6.167

7.  Rapid transient isoform-specific neuregulin1 transcription in motor neurons is regulated by neurotrophic factors and axon-target interactions.

Authors:  Jiajing Wang; Abdelkrim Hmadcha; Vaagn Zakarian; Fei Song; Jeffrey A Loeb
Journal:  Mol Cell Neurosci       Date:  2015-04-22       Impact factor: 4.314

8.  Effects of schizophrenia risk variation in the NRG1 gene on NRG1-IV splicing during fetal and early postnatal human neocortical development.

Authors:  Clare Paterson; Yanhong Wang; Joel E Kleinman; Amanda J Law
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

9.  Epigenetic meta-analysis across three civilian cohorts identifies NRG1 and HGS as blood-based biomarkers for post-traumatic stress disorder.

Authors:  Monica Uddin; Andrew Ratanatharathorn; Don Armstrong; Pei-Fen Kuan; Allison E Aiello; Evelyn J Bromet; Sandro Galea; Karestan C Koenen; Benjamin Luft; Kerry J Ressler; Derek E Wildman; Caroline M Nievergelt; Alicia Smith
Journal:  Epigenomics       Date:  2018-11-20       Impact factor: 4.778

10.  Reversal of behavioral deficits and synaptic dysfunction in mice overexpressing neuregulin 1.

Authors:  Dong-Min Yin; Yong-Jun Chen; Yi-Sheng Lu; Jonathan C Bean; Anupama Sathyamurthy; Chengyong Shen; Xihui Liu; Thiri W Lin; Clifford A Smith; Wen-Cheng Xiong; Lin Mei
Journal:  Neuron       Date:  2013-05-22       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.